Efficacy and safety are the two considerations when characterising the effects of a new therapy. We sought to apply an innovative method of assessing the benefit–risk balance using data from a ...

AEA Papers and Proceedings, Vol. 112, PAPERS AND PROCEEDINGS OF THE One Hundred Thirty-Fourth Annual Meeting OF THE AMERICAN ECONOMIC ASSOCIATION (MAY 2022), pp. 624-629 (6 pages) In this paper, ...

Type I error and power rates for pairwise comparisons of means were obtained from a Monte Carlo investigation of the Gabriel (1978) and Hochberg (1974) multiple ...